Cancer Stem Cell Immunoediting by IFNγ
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Champiat S, Ferrara R, Massard C, Besse B, Marabelle A, Soria J
. Hyperprogressive disease: recognizing a novel pattern to improve patient management. Nat Rev Clin Oncol. 2018; 15(12):748-762.
DOI: 10.1038/s41571-018-0111-2.
View
2.
Beziaud L, Young C, Madurga Alonso A, Norkin M, Minafra A, Huelsken J
. IFNγ-induced stem-like state of cancer cells as a driver of metastatic progression following immunotherapy. Cell Stem Cell. 2023; 30(6):818-831.e6.
DOI: 10.1016/j.stem.2023.05.007.
View
3.
Gocher A, Workman C, Vignali D
. Interferon-γ: teammate or opponent in the tumour microenvironment?. Nat Rev Immunol. 2021; 22(3):158-172.
PMC: 8688586.
DOI: 10.1038/s41577-021-00566-3.
View
4.
Vitale I, Manic G, De Maria R, Kroemer G, Galluzzi L
. DNA Damage in Stem Cells. Mol Cell. 2017; 66(3):306-319.
DOI: 10.1016/j.molcel.2017.04.006.
View
5.
De Martino M, Vanpouille-Box C
. Type I interferon induces cancer stem cells-mediated chemotherapy resistance. Oncoimmunology. 2022; 11(1):2127274.
PMC: 9518997.
DOI: 10.1080/2162402X.2022.2127274.
View